Potential Neuroprotection With ACTHAR Following Acute Optic Neuritis
Phase of Trial: Phase 0
Latest Information Update: 24 Aug 2017
Price : $35 *
At a glance
- Drugs Corticotropin (Primary)
- Indications Optic neuritis
- Focus Therapeutic Use
- 17 Aug 2017 Status changed from recruiting to completed.
- 22 Jan 2016 Planned primary completion date changed from 1 Dec 2015 to 1 Dec 2016 as reported by ClinicalTrials.gov.
- 25 Nov 2013 New trial record